Table of Content

1 Intracranial Atherosclerotic Disease Treatment Market Overview
1.1 Product Overview and Scope of Intracranial Atherosclerotic Disease Treatment
1.2 Intracranial Atherosclerotic Disease Treatment Segment by Type
1.2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Intracranial Atherosclerotic Disease Treatment Segment by Application
1.3.1 Intracranial Atherosclerotic Disease Treatment Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Intracranial Atherosclerotic Disease Treatment Market Size Estimates and Forecasts
1.4.1 Global Intracranial Atherosclerotic Disease Treatment Revenue 2016-2027
1.4.2 Global Intracranial Atherosclerotic Disease Treatment Sales 2016-2027
1.4.3 Intracranial Atherosclerotic Disease Treatment Market Size by Region: 2016 Versus 2021 Versus 2027

2 Intracranial Atherosclerotic Disease Treatment Market Competition by Manufacturers
2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Manufacturers (2016-2021)
2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Intracranial Atherosclerotic Disease Treatment Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Intracranial Atherosclerotic Disease Treatment Manufacturing Sites, Area Served, Product Type
2.5 Intracranial Atherosclerotic Disease Treatment Market Competitive Situation and Trends
2.5.1 Intracranial Atherosclerotic Disease Treatment Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Intracranial Atherosclerotic Disease Treatment Players Market Share by Revenue
2.5.3 Global Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Intracranial Atherosclerotic Disease Treatment Retrospective Market Scenario by Region
3.1 Global Intracranial Atherosclerotic Disease Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Intracranial Atherosclerotic Disease Treatment Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
3.3.1 North America Intracranial Atherosclerotic Disease Treatment Sales by Country
3.3.2 North America Intracranial Atherosclerotic Disease Treatment Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
3.4.1 Europe Intracranial Atherosclerotic Disease Treatment Sales by Country
3.4.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Region
3.5.1 Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Region
3.5.2 Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
3.6.1 Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country
3.6.2 Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
3.7.1 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Country
3.7.2 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Intracranial Atherosclerotic Disease Treatment Historic Market Analysis by Type
4.1 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2016-2021)
4.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2016-2021)
4.3 Global Intracranial Atherosclerotic Disease Treatment Price by Type (2016-2021)

5 Global Intracranial Atherosclerotic Disease Treatment Historic Market Analysis by Application
5.1 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2016-2021)
5.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2016-2021)
5.3 Global Intracranial Atherosclerotic Disease Treatment Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Stryker
6.1.1 Stryker Corporation Information
6.1.2 Stryker Description and Business Overview
6.1.3 Stryker Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Stryker Product Portfolio
6.1.5 Stryker Recent Developments/Updates
6.2 Balt
6.2.1 Balt Corporation Information
6.2.2 Balt Description and Business Overview
6.2.3 Balt Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Balt Product Portfolio
6.2.5 Balt Recent Developments/Updates
6.3 TERUMO
6.3.1 TERUMO Corporation Information
6.3.2 TERUMO Description and Business Overview
6.3.3 TERUMO Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2016-2021)
6.3.4 TERUMO Product Portfolio
6.3.5 TERUMO Recent Developments/Updates
6.4 MicroPort
6.4.1 MicroPort Corporation Information
6.4.2 MicroPort Description and Business Overview
6.4.3 MicroPort Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2016-2021)
6.4.4 MicroPort Product Portfolio
6.4.5 MicroPort Recent Developments/Updates
6.5 Acandis
6.5.1 Acandis Corporation Information
6.5.2 Acandis Description and Business Overview
6.5.3 Acandis Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Acandis Product Portfolio
6.5.5 Acandis Recent Developments/Updates

7 Intracranial Atherosclerotic Disease Treatment Manufacturing Cost Analysis
7.1 Intracranial Atherosclerotic Disease Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intracranial Atherosclerotic Disease Treatment
7.4 Intracranial Atherosclerotic Disease Treatment Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Intracranial Atherosclerotic Disease Treatment Distributors List
8.3 Intracranial Atherosclerotic Disease Treatment Customers

9 Intracranial Atherosclerotic Disease Treatment Market Dynamics
9.1 Intracranial Atherosclerotic Disease Treatment Industry Trends
9.2 Intracranial Atherosclerotic Disease Treatment Growth Drivers
9.3 Intracranial Atherosclerotic Disease Treatment Market Challenges
9.4 Intracranial Atherosclerotic Disease Treatment Market Restraints

10 Global Market Forecast
10.1 Intracranial Atherosclerotic Disease Treatment Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Intracranial Atherosclerotic Disease Treatment by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Intracranial Atherosclerotic Disease Treatment by Type (2022-2027)
10.2 Intracranial Atherosclerotic Disease Treatment Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Intracranial Atherosclerotic Disease Treatment by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Intracranial Atherosclerotic Disease Treatment by Application (2022-2027)
10.3 Intracranial Atherosclerotic Disease Treatment Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intracranial Atherosclerotic Disease Treatment by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Intracranial Atherosclerotic Disease Treatment by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Intracranial Atherosclerotic Disease Treatment Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Intracranial Atherosclerotic Disease Treatment Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Intracranial Atherosclerotic Disease Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Intracranial Atherosclerotic Disease Treatment Covered in This Study
Table 5. Global Intracranial Atherosclerotic Disease Treatment Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Manufacturers (2016-2021)
Table 7. Global Intracranial Atherosclerotic Disease Treatment Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Intracranial Atherosclerotic Disease Treatment Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Intracranial Atherosclerotic Disease Treatment Manufacturing Sites and Area Served
Table 11. Manufacturers Intracranial Atherosclerotic Disease Treatment Product Type
Table 12. Global Intracranial Atherosclerotic Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Intracranial Atherosclerotic Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intracranial Atherosclerotic Disease Treatment as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2016-2021) & (K Units)
Table 16. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2016-2021)
Table 17. Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021) & (K Units)
Table 19. North America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2016-2021)
Table 20. North America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2016-2021)
Table 22. Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021) & (K Units)
Table 23. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2016-2021)
Table 24. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2016-2021)
Table 30. Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2016-2021)
Table 32. Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2016-2021)
Table 38. Global Intracranial Atherosclerotic Disease Treatment Sales (K Units) by Type (2016-2021)
Table 39. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2016-2021)
Table 40. Global Intracranial Atherosclerotic Disease Treatment Revenue (Million US$) by Type (2016-2021)
Table 41. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Type (2016-2021)
Table 42. Global Intracranial Atherosclerotic Disease Treatment Price (US$/Unit) by Type (2016-2021)
Table 43. Global Intracranial Atherosclerotic Disease Treatment Sales (K Units) by Application (2016-2021)
Table 44. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2016-2021)
Table 45. Global Intracranial Atherosclerotic Disease Treatment Revenue (Million US$) by Application (2016-2021)
Table 46. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Application (2016-2021)
Table 47. Global Intracranial Atherosclerotic Disease Treatment Price (US$/Unit) by Application (2016-2021)
Table 48. Stryker Corporation Information
Table 49. Stryker Description and Business Overview
Table 50. Stryker Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Stryker Intracranial Atherosclerotic Disease Treatment Product
Table 52. Stryker Recent Developments/Updates
Table 53. Balt Corporation Information
Table 54. Balt Description and Business Overview
Table 55. Balt Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Balt Intracranial Atherosclerotic Disease Treatment Product
Table 57. Balt Recent Developments/Updates
Table 58. TERUMO Corporation Information
Table 59. TERUMO Description and Business Overview
Table 60. TERUMO Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. TERUMO Intracranial Atherosclerotic Disease Treatment Product
Table 62. TERUMO Recent Developments/Updates
Table 63. MicroPort Corporation Information
Table 64. MicroPort Description and Business Overview
Table 65. MicroPort Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. MicroPort Intracranial Atherosclerotic Disease Treatment Product
Table 67. MicroPort Recent Developments/Updates
Table 68. Acandis Corporation Information
Table 69. Acandis Description and Business Overview
Table 70. Acandis Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Acandis Intracranial Atherosclerotic Disease Treatment Product
Table 72. Acandis Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Intracranial Atherosclerotic Disease Treatment Distributors List
Table 76. Intracranial Atherosclerotic Disease Treatment Customers List
Table 77. Intracranial Atherosclerotic Disease Treatment Market Trends
Table 78. Intracranial Atherosclerotic Disease Treatment Growth Drivers
Table 79. Intracranial Atherosclerotic Disease Treatment Market Restraints
Table 80. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Type (2022-2027) & (K Units)
Table 81. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share Forecast by Type (2022-2027)
Table 82. Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 83. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share Forecast by Type (2022-2027)
Table 84. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Application (2022-2027) & (K Units)
Table 85. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share Forecast by Application (2022-2027)
Table 86. Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 87. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share Forecast by Application (2022-2027)
Table 88. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Region (2022-2027) & (K Units)
Table 89. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share Forecast by Region (2022-2027)
Table 90. Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 91. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share Forecast by Region (2022-2027)
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intracranial Atherosclerotic Disease Treatment
Figure 2. Global Intracranial Atherosclerotic Disease Treatment Market Share by Type in 2020 & 2027
Figure 3. Stent Product Picture
Figure 4. PTA Balloon Product Picture
Figure 5. Global Intracranial Atherosclerotic Disease Treatment Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Intracranial Atherosclerotic Disease Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Intracranial Atherosclerotic Disease Treatment Market Size 2016-2027 (US$ Million)
Figure 11. Global Intracranial Atherosclerotic Disease Treatment Sales 2016-2027 (K Units)
Figure 12. Global Intracranial Atherosclerotic Disease Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Intracranial Atherosclerotic Disease Treatment Sales Share by Manufacturers in 2020
Figure 14. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Intracranial Atherosclerotic Disease Treatment Players: Market Share by Revenue in 2020
Figure 16. Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2016-2021)
Figure 18. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region in 2020
Figure 19. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2016-2021)
Figure 20. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region in 2020
Figure 21. U.S. Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Intracranial Atherosclerotic Disease Treatment by Type (2016-2021)
Figure 46. Sales Market Share of Intracranial Atherosclerotic Disease Treatment by Application (2016-2021)
Figure 47. Sales Market Share of Intracranial Atherosclerotic Disease Treatment by Application in 2020
Figure 48. Revenue Share of Intracranial Atherosclerotic Disease Treatment by Application (2016-2021)
Figure 49. Revenue Share of Intracranial Atherosclerotic Disease Treatment by Application in 2020
Figure 50. Manufacturing Cost Structure of Intracranial Atherosclerotic Disease Treatment
Figure 51. Manufacturing Process Analysis of Intracranial Atherosclerotic Disease Treatment
Figure 52. Intracranial Atherosclerotic Disease Treatment Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed